机译:2019年新型冠状病毒的受体结合结构域(RBD)的表征:对RBD蛋白作为病毒附着抑制剂和疫苗的影响意义
Lindsley F.Kimball Research Institute New York Blood Center New York NY USA;
Beijing Institute of Microbiology and Epidemiology Beijing China;
Lindsley F.Kimball Research Institute New York Blood Center New York NY USA;
Lindsley F.Kimball Research Institute New York Blood Center New York NY USAKey Laboratory of Medical Molecular Virology(MOE/NHC/CAMS) School of Basic Medical Sciences Fudan University Shanghai China;
Lindsley F.Kimball Research Institute New York Blood Center New York NY USA;
Lindsley F.Kimball Research Institute New York Blood Center New York NY USAKey Laboratory of Medical Molecular Virology(MOE/NHC/CAMS) School of Basic Medical Sciences Fudan University Shanghai China;
Beijing Institute of Microbiology and Epidemiology Beijing China;
Lindsley F.Kimball Research Institute New York Blood Center New York NY USA;
2019 novel coronavirus; SARS-CoV-2; spike protein; receptor-binding domain; viral inhibitor; cross-neutralization;